Nasal drugs are opening the door to new therapies for everything from smoking cessation to Alzheimer s. The upshot? Someday, inhaling therapies could be as routine as swallowing pills.
Impel Pharmaceuticals Inc. (NASDAQ:IMPL – Get Rating)’s stock price dropped 7.6% during trading on Monday . The company traded as low as $1.22 and last traded at $1.22. Approximately 20,793 shares changed hands during trading, a decline of 59% from the average daily volume of 50,243 shares. The stock had previously closed at $1.32. Impel […]
Shares of Impel Pharmaceuticals Inc. (IMPL) are gaining 17% on Wednesday morning, after losing nearly 55% in the past few days since it released its first quarter results last Friday.
Impel Pharmaceuticals Inc. (NASDAQ:IMPL – Get Rating) was the recipient of a large increase in short interest in April. As of April 30th, there was short interest totalling 424,400 shares, an increase of 8.9% from the April 15th total of 389,700 shares. Approximately 5.5% of the shares of the stock are short sold. Based on […]
Impel Pharmaceuticals Inc. (NASDAQ:IMPL – Get Rating) was the recipient of a large increase in short interest in April. As of April 30th, there was short interest totalling 424,400 shares, an increase of 8.9% from the April 15th total of 389,700 shares. Based on an average trading volume of 46,600 shares, the days-to-cover ratio is […]